For research use only. Not for therapeutic Use.
WWL229（Cat No.:R024470）is a selective inhibitor of α/β-hydrolase domain-containing protein 6 (ABHD6), an enzyme involved in the hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG). By inhibiting ABHD6, WWL229 increases 2-AG levels, thereby enhancing cannabinoid receptor signaling, particularly through CB1 and CB2 receptors. This modulation influences various physiological processes, including inflammation, pain, and neuroprotection. WWL229 is commonly used in preclinical research to explore the therapeutic potential of endocannabinoid system modulation in neurological disorders, metabolic diseases, and inflammatory conditions. Its selectivity makes it a valuable tool for dissecting ABHD6-related signaling pathways.
| CAS Number | 1338575-28-2 |
| Synonyms | (4-nitrophenyl) 2-(3-methoxypropyl)piperidine-1-carboxylate |
| Molecular Formula | C16H22N2O5 |
| Purity | ≥95% |
| IUPAC Name | (4-nitrophenyl) 2-(3-methoxypropyl)piperidine-1-carboxylate |
| InChI | InChI=1S/C16H22N2O5/c1-22-12-4-6-13-5-2-3-11-17(13)16(19)23-15-9-7-14(8-10-15)18(20)21/h7-10,13H,2-6,11-12H2,1H3 |
| InChIKey | XVBRVSAGMWRVCK-UHFFFAOYSA-N |
| SMILES | COCCCC1CCCCN1C(=O)OC2=CC=C(C=C2)[N+](=O)[O-] |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
